2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
One particularly interesting case involves a patient with a clinical diagnosis<br />
<strong>of</strong> autosomal recessive multi-minicore disease in whom we<br />
found three RYR1 mutations - two missense mutations previously reported<br />
as pathogenic and one previously unreported three base pair<br />
deletion .<br />
In addition to causing congenital myopathy, mutations in certain regions<br />
<strong>of</strong> the RYR1 gene are also associated with malignant hyperthermia<br />
susceptibility (MHS) and it is important that the implications <strong>of</strong> this<br />
are clearly explained to other family members .<br />
P05.174<br />
Role <strong>of</strong> Attct repeat interruptions in spinocerebellar ataxia<br />
type 10<br />
I. Alonso 1 , T. Almeida 1 , L. B. Jardim 2 , O. Artigalas 2 , M. L. Saraiva-Pereira 2 , T.<br />
Matsuura 3 , J. Sequeiros 1,4 , I. Silveira 1 ;<br />
1 UnIGENe - IBMC, Univ. Porto, Porto, Portugal, 2 Hosp. Clinicas de Porto<br />
Alegre, Porto Alegre, Brazil, 3 Center for Neurological Diseases and Cancer,<br />
Nagoya University Graduate School <strong>of</strong> Medicine, Nagoya, Japan, 4 ICBAS, Univ.<br />
Porto, Porto, Portugal.<br />
Spinocerebellar ataxia type 10 (SCA10) is a dominant neurological<br />
disease, caused by the expansion <strong>of</strong> an (ATTCT)n in intron 9 <strong>of</strong><br />
ATXN10, <strong>of</strong> still unknown function. SCA10 was first described in Mexican<br />
families with ataxia and seizures . We have previously described<br />
an expansion <strong>of</strong> the ATTCT repeat in two Brazilian families presenting<br />
ataxia without seizures . We found reduced penetrance alleles <strong>of</strong> 360-<br />
370 repeats, in elderly asymptomatic subjects .<br />
To investigate a previous hypothesis <strong>of</strong> interruptions in the (ATTCT)n<br />
tract, functioning as a disease modifier, we assessed the interruption<br />
in another family with ataxia and seizures, and more than 2000 ATTCT<br />
units .<br />
By a modified PCR technique, an abnormal discontinuous ladder, exceeding<br />
the range observed for normal alleles, was detected in this<br />
Brazilian family, presenting progressive cerebellar ataxia with associated<br />
seizures and onset during or after the 3 rd decade . This suggested<br />
the presence <strong>of</strong> interruptions within the ATTCT expansion. Modified<br />
PCR products <strong>of</strong> patients showing an interrupted pattern were agarose-gel<br />
purified and cloned with TOPO TA cloning kit for sequencing<br />
analysis and determination <strong>of</strong> the interrupted motif .<br />
In this family, the ATTCT repeat seems to be interrupted by a large<br />
stretch, unrelated to the repeat sequence, and patients show progressive<br />
cerebellar ataxia with associated seizures . In contrast, the previous<br />
SCA10 families identified by us, showed cerebellar ataxia without<br />
seizures, caused by the expansion <strong>of</strong> uninterrupted ATTCT tracts . This<br />
newly identified family reinforces the hypothesis that interruptions in<br />
the (ATTCT)n tract function as a disease modifier.<br />
P05.175<br />
Ribosomal frameshifting on expanded ATXN transcripts: a<br />
Drosophila model<br />
C. Gaspar 1 , S. Stochmanski 1 , J. Laganière 1 , M. Therrien 1 , D. Rochefort 1 , D.<br />
Van Meyel 2 , G. A. Rouleau 1 ;<br />
1 Centre <strong>of</strong> Excellence in Neuromics, Université de Montréal, Montreal, QC,<br />
Canada, 2 Centre for Research in Neuroscience, McGill University, Montreal,<br />
QC, Canada.<br />
Background: Spinocerebellar ataxia type 3 (SCA3) is caused by the<br />
expansion <strong>of</strong> a coding CAG repeat in the ATXN3 gene . We have previously<br />
shown that the expanded CAG repeat in SCA3 is prone to -1<br />
ribosomal frameshifting, leading to the production and aggregation <strong>of</strong><br />
proteins containing polyalanine stretches . These frameshifted molecules<br />
confer increased toxicity to cells when compared to constructs<br />
containing expanded CAA repeats, which code for polyglutamine in the<br />
main frame but lack the ability to frameshift into an alanine frame . Anisomycin<br />
(a ribosome interacting antibiotic that reduces -1 frameshifting)<br />
decreases frameshifting in expanded CAG tracts and ameliorates<br />
the cellular toxic phenotype .<br />
Aims: To model expCAG repeat -1 frameshifting in vivo; to assess the<br />
contribution <strong>of</strong> -1 frameshifting to expCAG toxicity in the fly.<br />
Methods: Full-length ATXN3 Drosophila transgenic lines carrying either<br />
wtCAG, expCAG or expCAA constructs containing epitope tags in<br />
the three possible reading frames were generated and comparatively<br />
analysed .<br />
Results: We show that: (1) transgenic expression <strong>of</strong> expCAG ATXN3<br />
constructs is deleterious in the fly; (2) transgenic expression <strong>of</strong> exp-<br />
CAA ATXN3 constructs, despite adequate levels <strong>of</strong> protein expression,<br />
is not toxic; (3) -1 frameshifting occurs in Drosophila and is restricted to<br />
the expanded CAG transgenic lines .<br />
Conclusions: We propose that -1 ribosomal frameshifting is a major<br />
contributor to the toxicity observed in expanded CAG repeat diseases .<br />
This novel pathological mechanism may open new therapeutic opportunities<br />
for these diseases .<br />
P05.176<br />
mutation analysis <strong>of</strong> the scN1A gene and genotype-phenotype<br />
correlations in Bulgarian epilepsy patients<br />
I. Yordanova 1,2 , L. Claes 3 , I. Ivanov 4 , A. Suls 3 , I. Litvinenko 5 , P. Dimova 6 , D.<br />
Hristova 5 , V. Bozinova 6 , I. Kremensky 1,2 , P. De Jonghe 3 , A. Jordanova 2,3 ;<br />
1 National <strong>Genetics</strong> Laboratory, S<strong>of</strong>ia, Bulgaria, 2 Molecular Medicine Center,<br />
Medical University, S<strong>of</strong>ia, Bulgaria, 3 VIB Department <strong>of</strong> Molecular <strong>Genetics</strong>,<br />
University <strong>of</strong> Antwerp, Antwerpen, Belgium, 4 Department <strong>of</strong> Pediatrics, Medical<br />
University, Plovdiv, Bulgaria, 5 Department <strong>of</strong> Pediatrics, Medical University,<br />
S<strong>of</strong>ia, Bulgaria, 6 Department <strong>of</strong> Neurology, Medical University, S<strong>of</strong>ia, Bulgaria.<br />
Epilepsy is a common neurological disease, affecting more than 1%<br />
<strong>of</strong> people from any age, gender and ethnical origin . Mutations in the<br />
alpha1-subunit (α1) <strong>of</strong> the neuronal voltage gated sodium channel<br />
Na v 1 .1, are associated with generalized epilepsy with febrile seizures<br />
plus (GEFS+) and severe myoclonic epilepsy in infancy (SMEI) . It is<br />
encoded by 26 exons <strong>of</strong> the SCN1A gene on chromosome 2q24 .<br />
We performed a mutation analysis <strong>of</strong> SCN1A in 28 patients with<br />
GEFS+, 20 with SMEI and 62 with other types <strong>of</strong> infantile epilepsy .<br />
Genomic DNA was extracted from peripheral blood lymphocytes using<br />
a standard sodium chloride precipitation method . The SCN1A point<br />
mutation screening included PCR analysis followed by direct sequencing<br />
<strong>of</strong> all exons and exon-intron boundaries <strong>of</strong> the gene . In addition, all<br />
patients were analyzed for exonic deletions and duplications by MAQ<br />
assay .<br />
We identified 11 disease-causing mutations, including 6 missense,<br />
2 nonsense, 1 splice-site mutation and 2 single base deletions . Two<br />
missense and all truncating mutations were found in SMEI patients,<br />
consistent with the severity <strong>of</strong> the epilepsy phenotype . Four GEFS+<br />
patients carried a missense mutation. All mutations we identified had<br />
not been reported in the literature. This is the first large scale study <strong>of</strong><br />
SCN1A gene analysis in Bulgarian epilepsy patients .<br />
In our sample, a mutation was identified in 23% <strong>of</strong> patients with GEFS+<br />
or SMEI, and none in the other epilepsy patients . This nicely illustrates<br />
that GEFS+ and SMEI are part <strong>of</strong> a continuous spectrum <strong>of</strong> fever associated<br />
epilepsy phenotypes caused by mutations in SCN1A .<br />
P05.177<br />
KPQ del in SCN5a gene in two different types <strong>of</strong> SCD in one<br />
family<br />
S. Saber 1 , K. Banihashemi 1 , M. Eftekharzadeh 2 , M. KhosroHeidari1 1 , m. a.<br />
SadrAmeli 3 , A. F. Fazelifar 3 , M. Haghjoo 3 , m. Houshmand 4 , E. V. Zaklyazminskaya<br />
5 ;<br />
1 Special medical center genetic lab ward , Russian Academy <strong>of</strong> Science DNA<br />
lab, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Tehran clinic arrhythmia center, Tehran,<br />
Islamic Republic <strong>of</strong> Iran, 3 Heart center shahid Rajaee hospital electrophysiology<br />
ward, Tehran, Islamic Republic <strong>of</strong> Iran, 4 Special medical center genetic lab<br />
ward, Tehran, Islamic Republic <strong>of</strong> Iran, 5 Russian Academy <strong>of</strong> Science DNA lab,<br />
Moscow, Russian Federation.<br />
Cardiac action potentials are generated and propagated through the<br />
coordinated activity <strong>of</strong> multiple ion channels, including voltage-gated<br />
sodium channels, calcium channels and potassium channels . Mutations<br />
in genes encoding these channels cause familial arrhythmias .<br />
Heart rhythm disturbances constituent some inherited syndromes any<br />
kind <strong>of</strong> genetic nature<br />
Many kinds <strong>of</strong> arrhythmia caused SCD (sudden cardiac death) and<br />
the prevalence <strong>of</strong> SCD is 1: 1000 individuals . Some <strong>of</strong> SCDs were<br />
caused by Na channelopathy such as LQT3 and Brugada Syn these<br />
are two <strong>of</strong> main caused <strong>of</strong> sudden cardiac death in young people with<br />
out any detectable cardiac abnormality with routine tests and we know<br />
that Brugada syndrome was caused by loss <strong>of</strong> function <strong>of</strong> Na channel<br />
and LQT3 was caused by gain <strong>of</strong> function Na channel in heart . . We<br />
can check SCN5a gene for ruling out <strong>of</strong> this gene as a main gene<br />
<strong>of</strong> Na channelopathy in heart arrhythmias . We check by SSCP and<br />
Sequencing this gene . We checked SCN5A in a family with 11 affected<br />
person that approved by ECG and EPS study and some persons